MarketInOut Stock Screener Log In | Sign Up

D&D Pharmatech Co Ltd

KRX • Healthcare • Biotechnology • Quote as of 10/28/2026 15:30
D&D Pharmatech Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization1,867,882 mln
Float30.08 mln

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

0.95
Highly suspicious

Relative Strength

98 / 100
Top performer

Debt / Equity

0.85
Moderate leverage

Pre-Tax Margin

-630%
Severely loss-making

ROE

-18.34
Negative

Business Description

Founded in 2014 and headquartered in Seongnam-si, South Korea, D&D Pharmatech is a drug research and manufacturing company focused on developing treatments for serious medical conditions. Its pipeline includes medicines for weight management, liver disease, Parkinson's disease, Alzheimer's disease, and certain cancers, delivered in both pill and injectable forms. The company is also working on diagnostic tools to detect tumors and brain inflammation.

Key Fundamentals

EPS-580
ROE-18.34
RPS63.00
ROIC-43.66
ROA-11.58
EBITDA, mln-8,569
EV / EBITDA-213
EV / EBIT-128
Revenue, mln2,750
EV / Revenue663

Quote Details

Last 42,900
Change 2100 (5.15%)
Open 40,800
Volume 641,821
Turnover 27,534,120,960
Average Volume 523,798

Financial Ratios

Pre-Tax Profit Margin-630
Current Ratio27.21
Price / Book14.31
Price / Tangible Book18.57
Debt / Equity0.85
Price / Sales667

Financial Strength

Altman Z-Score5.21
Piotroski F-Score 2 / 9
Beneish M-Score0.95

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.92% 57 / 100   
1 Month -3.6% 62 / 100   
2 Months -37.55% 4 / 100   
6 Months -46.24% 17 / 100   
1 Year 1.96% 66 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog